Mount Sinai Unveils Real-Time Intraocular Pressure Monitoring in Glaucoma Surgery

Why It Matters

Real‑time intraoperative data could dramatically improve glaucoma surgery success rates and reduce postoperative complications, addressing a long‑standing gap in ophthalmic care.

Key Takeaways

• miDOC measured pressure, flow, outflow facility, and ocular compliance intraoperatively.
• First 20 human cases showed surgeons could adjust technique in real time.
• Device remains investigational, pending FDA clearance after successful early trials.
• Potential expands to cataract surgery, detecting pressure spikes before patient leaves table.

Pulse Analysis

Glaucoma surgery has long suffered from a lack of intraoperative feedback, forcing surgeons to rely on post‑operative outcomes to gauge success. Traditional approaches such as trabeculectomy and drainage implants succeed in fewer than half of cases because clinicians cannot see real‑time fluid dynamics. miDOC bridges this data gap by delivering continuous measurements of intraocular pressure, aqueous flow, outflow facility and ocular compliance, effectively turning a blind procedure into a data‑driven one. This mirrors the transformation optical biometry brought to cataract surgery, promising a new standard of precision for glaucoma interventions.

The initial human series, limited to 20 cases at the New York Eye and Ear Infirmary of Mount Sinai, demonstrated that surgeons could instantly see how each incision or implant altered ocular biomechanics. That immediate insight allowed on‑the‑fly adjustments, potentially reducing the high failure rates that have plagued glaucoma procedures for decades. While the device is still investigational and awaiting FDA clearance, the early outcomes have generated enthusiasm among ophthalmic innovators, suggesting a shorter learning curve and higher reproducibility across surgeons and institutions.

Beyond glaucoma, miDOC’s real‑time biometrics open doors for broader ophthalmic applications. In cataract surgery, where postoperative pressure spikes can threaten vision, intraoperative monitoring could identify at‑risk eyes before they leave the operating table. Researchers are also exploring choroidal blood‑flow detection, which could flag early signs of complex retinal diseases. If regulatory approval follows, miDOC could become a cornerstone technology, driving new revenue streams for device manufacturers and reshaping surgical protocols across the eye‑care market.